Celon Pharma
CLN.WA
6,31 €
Share price
-1.31%
Change (1 day)
76.99%
Change (1 year)
Categories
P/S ratio for Celon Pharma (CLN.WA)
P/S ratio as of April 2025 (TTM): 8.02
According to Celon Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.72. At the end of 2024 the company had a P/S ratio of 8.34.
P/S ratio history for Celon Pharma from 2017 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 8.34 | 63.88% |
| 2023 | 5.09 | 12.31% |
| 2022 | 4.53 | -48.92% |
| 2021 | 8.87 | -35.56% |
| 2020 | 13.8 | -22.05% |
| 2019 | 17.7 | 61.69% |
| 2018 | 10.9 | -31.59% |
| 2017 | 16.0 |